UiPath Inc. (NYSE:PATH) Stock Holdings Decreased by Stanley Laman Group Ltd.

Stanley Laman Group Ltd. reduced its position in UiPath Inc. (NYSE:PATH) by 6.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 402,655 shares of the healthcare company’s stock after selling 29,809 shares during the period. Stanley Laman Group Ltd. owned about 0.07% of UiPath worth $5,154,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Future Financial Wealth Managment LLC acquired a new stake in shares of UiPath in the third quarter worth $26,000. JTC Employer Solutions Trustee Ltd acquired a new stake in shares of UiPath in the third quarter worth $26,000. ORG Partners LLC lifted its stake in shares of UiPath by 875.6% in the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after buying an additional 1,112 shares during the last quarter. Hantz Financial Services Inc. acquired a new position in UiPath during the 2nd quarter valued at $28,000. Finally, Redwood Wealth Management Group LLC acquired a new position in UiPath during the 2nd quarter valued at $43,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 22.37% of the company’s stock.

UiPath Trading Down 3.2 %

NYSE:PATH opened at $12.63 on Wednesday. UiPath Inc. has a 1 year low of $10.37 and a 1 year high of $27.87. The stock has a market cap of $6.95 billion, a price-to-earnings ratio of -63.15 and a beta of 0.88. The stock has a 50-day moving average price of $12.44 and a two-hundred day moving average price of $14.30.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.09) earnings per share. Sell-side analysts forecast that UiPath Inc. will post -0.23 earnings per share for the current year.

Wall Street Analyst Weigh In

PATH has been the subject of a number of analyst reports. DA Davidson raised their price target on shares of UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Morgan Stanley reissued an “equal weight” rating and set a $15.00 price objective on shares of UiPath in a report on Friday, September 6th. TD Cowen lowered their target price on shares of UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, September 6th. Wells Fargo & Company lifted their price target on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a report on Friday, September 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research note on Friday, September 6th. Sixteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, UiPath currently has an average rating of “Hold” and an average target price of $17.71.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.